Univest
Univest
  • Markets

Nifty Pharma Prediction for Tomorrow, 28 October 2026 (Including F&O)

  • October 27, 2026
  • Posted by: Kunal Singla
  • Category: Uncategorized
No Comments
Nifty Pharma Prediction for Tomorrow, 28 October 2026 (Including F&O)

Nifty Pharma closed at 26,267.25, up 1.91%. Nifty 50 was little changed, down 0.02%. India VIX fell 4.43% to 16.40. Next session is tomorrow, Wednesday 28 October.

Quick Answer

The nifty pharma prediction for tomorrow is constructive for tomorrow, 28 October 2026. Nifty Pharma rose 1.91 percent to 26,267.25 on Tuesday, following a 1.76 percent rise on Monday. It opened above the previous close of 25,774.25 and closed near the high.

This nifty pharma prediction for tomorrow follows a Tuesday, 27 October 2026 session in which the Nifty Pharma index rose 1.91 percent to 26,267.25, a second straight gain, closing near its high of 26,313.85.

Ankit Jaiswal, Senior Research Analyst at Univest, and Kunal Singla, Associate Director at Univest, are tracking sector-specific triggers and F&O positioning ahead of the session tomorrow, which falls on Wednesday, 28 October 2026.

Click Here – Get Free Investment Predictions

Table of Contents

Toggle
  • What Tuesday Told Us
  • Nifty Pharma Prediction for Tomorrow: Key Levels
  • Key Drivers for Tomorrow
  • Stocks and Triggers to Watch in the Nifty Pharma Space
  • How Tuesday’s Broader Session Unfolded
  • Analyst View for Tomorrow
  • Why This Is Written for Tomorrow
  • Risks to This Prediction
  • Conclusion
  • Frequently Asked Questions
    • What is the nifty pharma prediction for tomorrow?
    • Why is this a prediction for tomorrow, 28 October 2026?
    • Why did Nifty Pharma rise on Tuesday?
    • What are the key Nifty Pharma levels for tomorrow?
    • Is this a buy or sell call?

What Tuesday Told Us

  • Nifty Pharma closed at 26,267.25, up 1.91 percent on 27 October 2026.
  • The broader Nifty 50 fell 0.02 percent.
  • India VIX fell 4.43 percent to 16.40.

Nifty Pharma Prediction for Tomorrow: Key Levels

Nifty Pharma traded between 25,790.10 and 26,313.85 on Tuesday, against a previous close of 25,774.25, and settled at 26,267.25. On the downside, 25,790.10 and 25,774.25 are the first reference levels to watch if the day’s move is tested. On the upside, 26,313.85 marks the nearest resistance. Univest’s analysts treat these as reference points drawn from Tuesday’s trading range, not as targets.

Trend Support Resistance
Positive 25,790.10, 25,774.25 26,313.85

The table uses Tuesday’s high, low and previous close for Nifty Pharma.

Key Drivers for Tomorrow

  • Nifty Pharma rose 1.91 percent to 26,267.25, with a high of 26,313.85 and a low of 25,790.10.
  • The index never fell below the previous close, since its low of 25,790.10 sat above 25,774.25.
  • The Nifty 50 fell 0.02 percent, so pharma clearly outperformed the headline index.

Ankit Jaiswal and Kunal Singla suggest revisiting this nifty pharma prediction for tomorrow after the first thirty minutes of Wednesday’s trade.

Anyone following this nifty pharma prediction for tomorrow should keep the next session’s opening range in view before reading too much into early moves.

Stocks and Triggers to Watch in the Nifty Pharma Space

Nifty Pharma is a defensive-growth gauge. Two strong gains with a low above the previous close is a firm pattern. US generic pricing and export updates are the usual triggers.

In the F&O segment, the October Nifty and Bank Nifty contracts expired today, 27 October 2026, so tomorrow’s trade moves into the November series and expiry-day positioning resets. On the expiring October Nifty series, call open interest was highest at the 22,800 strike and put open interest was highest at the 22,750 strike, with a put-call ratio of approximately 1.04. India VIX fell 4.43 percent to 16.40, which points to somewhat calmer option pricing, and Univest’s analysts treat these strikes as reference points, not predictions.

Univest’s analysts suggest treating this nifty pharma prediction for tomorrow as a preparation note for Wednesday, 28 October 2026, rather than a signal that changes overnight.

These are educational views, not buy calls, and each should be checked against your own risk plan before acting.

How Tuesday’s Broader Session Unfolded

The Nifty 50 closed at 22,749.75, down 0.02 percent, with a high of 22,829.75 and a low of 22,636.85. The Sensex closed at 73,598.67, down 0.01 percent, and the Bank Nifty closed at 53,974.90, down 0.72 percent. India VIX, the market’s fear gauge, fell 4.43 percent to 16.40, after touching 17.49 during the session. The Nifty 50 ended almost flat and is about 1.7 percent below its close of 23,146.15 on 16 October. The Nifty Midcap 50 rose 0.90 percent and the Nifty Next 50 rose 1.30 percent, so the broader market outperformed the headline index. Nifty Pharma rose 1.91 percent and Nifty Auto rose 1.48 percent, while the Nifty Private Bank index fell 0.73 percent. The trigger for the divergence was not independently confirmed.

This nifty pharma prediction for tomorrow will be most useful when read alongside the support and resistance table above.

Analyst View for Tomorrow

Kunal Singla suggests that the index can hold above 25,774.25, the previous close, with a fresh high above 26,313.85 needed to extend the move.

Ankit Jaiswal flags that two strong sessions have pulled in buyers, so watching whether Wednesday’s open holds the gain matters.

A fair reading of this nifty pharma prediction for tomorrow is that Tuesday’s data sets the context, while Wednesday’s first hour decides how much of it carries forward.

Why This Is Written for Tomorrow

This nifty pharma prediction for tomorrow is written after the close on Tuesday, 27 October 2026, using Tuesday’s closing data, for the next trading session tomorrow, Wednesday, 28 October 2026. Treat it as a briefing to prepare for that session, not a live call that updates through the evening.

Track the Nifty Pharma Space on Univest Screeners

Readers comparing views should note that this nifty pharma prediction for tomorrow draws only on Tuesday’s closing numbers and the factors listed here.

Risks to This Prediction

  • After two strong gains, a pause or pullback is common.
  • A stronger rupee can hurt export earnings.
  • US regulatory news can move pharma stocks sharply.

As with any nifty pharma prediction for tomorrow, the opening minutes of Wednesday’s trade will confirm or challenge the levels discussed here.

The nifty pharma prediction for tomorrow also depends on India VIX, so a fresh rise in volatility would weaken the case made here.

Download the Univest iOS App or Univest Android App to get daily market recommendations and insightful research pieces.

Conclusion

The nifty pharma prediction for tomorrow leans constructive into 28 October 2026, with broader Nifty 50 direction and India VIX as the key variables to track. Ankit Jaiswal and Kunal Singla will revisit this view once Wednesday’s opening trade confirms direction.

For traders, this nifty pharma prediction for tomorrow is a framework for planning risk, with position size and stop levels left to the individual.

Disclaimer: Investments in securities are subject to market risk. Read all related documents carefully before investing. The information provided here is for educational purposes only and does not constitute investment advice. Univest is a SEBI-registered investment adviser (Registration No. INH000013776). Past performance is not indicative of future returns.

Frequently Asked Questions

What is the nifty pharma prediction for tomorrow?

Ans. It is constructive for 28 October 2026, after Nifty Pharma closed at 26,267.25 on Tuesday, up 1.91 percent.

Why is this a prediction for tomorrow, 28 October 2026?

Ans. Because it is written after the close on Tuesday, 27 October 2026, for the next regular trading session on Wednesday, 28 October 2026.

Why did Nifty Pharma rise on Tuesday?

Ans. Nifty Pharma rose 1.91 percent while the Nifty 50 fell 0.02 percent. The specific trigger was not independently confirmed.

What are the key Nifty Pharma levels for tomorrow?

Ans. The previous close of 25,774.25 and Tuesday’s low of 25,790.10 are support below the price, while Tuesday’s high of 26,313.85 is the nearest resistance.

Is this a buy or sell call?

Ans. No. This is an educational outlook from Univest’s research team, not a buy or sell call. Traders should check any view against their own risk plan before acting.



Nifty Pharma
Author: Kunal Singla
Kunal Singla is the Associate Director - Research at Univest, leading quantitative equity research, intraday trading setups, and derivatives strategy. With 4+ years of experience in Indian equity markets, he combines rigorous quantitative methods with classical technical analysis to build high-conviction research frameworks for retail and advisory clients. He holds an MSc from the Indian Institute of Technology (IIT) Delhi — one of India's most selective institutions — and has completed the Certificate in Quantitative Finance (CQF), a globally recognised programme covering derivatives pricing, risk modelling, machine learning for finance, and advanced portfolio theory. This combination places him in a small group of Indian analysts with both deep academic training in quantitative methods and SEBI-recognised research credentials. Kunal holds seven SEBI-recognised NISM certifications spanning research, derivatives, portfolio management, and securities operations: Series-XV (Research Analyst), Series-XXI-A (Portfolio Managers), Series-XVI (Commodity Derivatives), Series-VIII (Equity Derivatives), Series-VII (SORM), Series-V-A (Mutual Fund Distributors), and Series-I (Currency Derivatives). At Univest — India's SEBI-registered research and advisory platform — Kunal leads research inputs for Pro Lite, Pro Super, Pro Gold, and Pro Commodity advisory services, alongside publishing intraday stock picks on Univest Blogs.

Leave a Reply Cancel reply